Since the discovery of gonadotropin-releasing hormone (GnRH) in mammals at the beginning of the 1970s, it was generally accepted that GnRH is the only hypothalamic neuropeptide regulating gonadotropin release in mammals and other vertebrates. In 2000, however, gonadotropin-inhibitory hormone (GnIH), a novel hypothalamic neuropeptide that actively inhibits gonadotropin release, was discovered in...

BACKGROUND Gonadotropin cell is the main responsible for the secretion of follicle stimulating hormone (FSH) and luteinizing hormone (LH), and immunocastration reduces the concentrations of serum FSH and LH. A few studies have reported the histological structure of gonadotropin cells obtained from immunocastration animals at the light microscopy level. However, the ultrastructure of gonadotropi...

Gonadotropin-releasing hormone (GnRH) neurons in the preoptic area (POA) of the hypothalamus play a key role in regulating reproductive function. These neurons in turn are modulated by environmental influences, including the social environment. In both the Old World cichlid Astatotilapia burtoni and the New World cichlid Amatitlania nigrofasciatus, the size of the soma of GnRH expressing neuron...

gonadotropin releasing hormone (gnrh) plays a key role in reproduction. this decapeptide is synthesized and released by hypothalamus and induces the pituitary gonadotrop cells to release pituitary gonadotropin hormones. in some extrapituitary compartments gnrh and its receptor act as part of the autocrine regulatory system of cell proliferation. the anticancer activity of gnrh and its analogues...

Abstract Polycystic Ovarian Syndrome (PCOS) is a disease that characterized by an increased Gonadotropin-Releasing-Hormone (GnRH) pulsatile frequency, causing altered LH/FSH ratio. More precisely Luteinizing Hormone (LH) secretion compared to decreased Follicle-Stimulating (FSH) leads the development of hyperandrogenism and low-level concentration estrogens therefore negative estrogenic feedbac...

Objective To investigate the clinical effect of high intensity focused ultrasound (HIFU) ablation combined with gonadotropin-releasing hormone agonist (GnRH-a) and levonorgestrel-releasing intrauterine system (LNG-IUS) in treatment adenomyosis patients who failed to respond drug therapies.Study design A total 47 had therapies no fertility desires were treated HIFU GnRH-a LNG-IUS. The score dysm...